Antipsychotic medication
Showing 1 - 25 of >10,000
Maternal And Infant Antipsychotic Study
Not yet recruiting
- Antipsychotics
- Pregnancy
- Antipsychotics
- +2 more
- (no location specified)
Sep 16, 2023
Periodontitis in Schizophrenic Patients
Completed
- Schizophrenia Spectrum and Other Psychotic Disorders
- Periodontal Diseases
- antipsychotic drugs inducing hyperprolactinemia
-
Giza, EgyptRania Hassan Shalby
Sep 10, 2023
Affective Disorder, Psychosis Trial (Supervised exercise)
Not yet recruiting
- Affective Disorder
- Psychosis
- Supervised exercise
- (no location specified)
Jul 15, 2022
Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorders Trial (The Antipsychotic Medication Decision Aid (APM-DA))
Not yet recruiting
- Schizophrenia
- +4 more
- The Antipsychotic Medication Decision Aid (APM-DA)
- (no location specified)
Dec 7, 2022
Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder Trial in Toronto (Risperidone/Olanzapine and PET scans)
Completed
- Schizophrenia
- +4 more
- Risperidone/Olanzapine and PET scans
-
Toronto, Ontario, CanadaCentre for Addiction and Mental Health
Jun 2, 2022
Schizophrenia Trial in Miami (Aripiprazole Lauroxil, Computerized cognitive and functional skills training)
Not yet recruiting
- Schizophrenia
- Aripiprazole Lauroxil
- Computerized cognitive and functional skills training
-
Miami, FloridaJackson Memorial Hospital
Dec 14, 2022
Childhood Obesity Trial (Treatment, Control)
Enrolling by invitation
- Childhood Obesity
- Treatment
- Control
- (no location specified)
Nov 22, 2021
Breakthrough Symptoms With Long-Acting Injectable Medications
Not yet recruiting
- Schizophrenia
- Schizophrenia Relapse
- Second Generation Long-Acting Injectable Antipsychotic Medications
- (no location specified)
Jul 22, 2022
Deprescriptions, Antidepressive Agents, Antipsychotic Agents Trial in Bielefeld, Munich, Witten (PARTNER intervention, Control
Recruiting
- Deprescriptions
- +5 more
- PARTNER intervention
- Control intervention
-
Bielefeld, Germany
- +2 more
Apr 24, 2023
Metabolic Disturbance, Schizophrenia, Type 2 Diabetes Trial in Copenhagen (Semaglutide, 1.34 mg/mL, Semaglutide-)
Not yet recruiting
- Metabolic Disturbance
- +5 more
- Semaglutide, 1.34 mg/mL
- Semaglutide-placebo
-
Copenhagen, DenmarkPsychiatric Center Copenhagen, Rigshospitalet
Jun 30, 2021
Schizophrenia Trial in Changsha (Antipsychotic drugs, cTBS(the left temporoparietal cortex as the stimulation target), cTBS (the
Recruiting
- Schizophrenia
- Antipsychotic drugs
- +2 more
-
Changsha, ChinaThe Second Xiangya Hospital of Central South University
Mar 10, 2022
Schizophrenia, Schizoaffective Disorder, Substance Use Disorders Trial in Boston, Worcester, Chapel Hill (Brexpiprazole,
Recruiting
- Schizophrenia
- +2 more
- Brexpiprazole
- Treatment as Usual
-
Boston, Massachusetts
- +2 more
May 31, 2022
Schizophrenia Trial in Irving (SPD489 40mg, SPD489 100mg, SPD489 160mg)
Terminated
- Schizophrenia
- SPD489 40mg
- +3 more
-
Irving, TexasUniversity Hills Clinical Research
May 29, 2021
The National Register of Antipsychotic Medication in Pregnancy
Unknown status
- Pregnancy
- Mental Disorders
-
Melbourne, Victoria, AustraliaMonash Alfred Pyschiatry Research Centre, Alfred Hospital
Jan 6, 2020
Based on French National Health Insurance Database in Psychotic
Not yet recruiting
- Psychotic Disorders
- No Intervention
- (no location specified)
Nov 21, 2022
Mental Disorders, Severe Trial (TACTIC)
Not yet recruiting
- Mental Disorders, Severe
- TACTIC
- (no location specified)
Dec 8, 2022
Schizophrenia, Schizoaffective Disorder, Type 2 Diabetes Trial in Saint Louis (risperidone, olanzapine, quetiapine)
Schizophrenia;Schizoaffective Trial in Toronto (Active TDCS, Sham TDCS)
Recruiting
- Schizophrenia;Schizoaffective
- Active TDCS
- Sham TDCS
-
Toronto, Ontario, CanadaCentre for Addiction and Mental Health
Jun 2, 2022
Early Psychosis Trial in New York (Levetiracetam Pill, Placebo)
Recruiting
- Early Psychosis
- Levetiracetam Pill
- Placebo
-
New York, New YorkNYU Langone Health
Oct 27, 2022